StemRx Bioscience Solutions Pvt Ltd won the award in the Clinical Research category at the National Awards for Excellence in Healthcare event.

The event was organised by CMO Asia at the hotel Taj Lands End Mumbai on June 24, 2016. Senior professionals across the industry attended the event. The event was organized to recognize and reward professionals who lead innovative health practices.

StemRx Bioscience Solutions Pvt. Ltd., runs under the leadership of Dr. Pradeep. V. Mahajan who specializes in cellular therapy. He is a surgeon by qualification and has trained extensively in regenerative and cellular medicine both in India and the USA.

He firmly believes that conventional modalities of treatment only take care of the signs and symptoms but do not address the root cause of the disease or the ailment. With this belief StemRx was founded and till date cellular therapy for more than 75 different indications are being successfully undertaken by StemRx. More than 2000 patients with degenerative debilitating problems have been treated and have gone back happily.

StemRx has academic and research affiliation with Maharashtra University of Health Sciences and The Ohio State University. The company has an international patent for treatment of avascular necrosis. In collaboration with SanoStem and Stemedica International (USA), a clinical trial for Osteoarthritis and Diabetes Mellitus will be initiated in India.

“StemRx continually strives to excel in the healthcare sector in order to provide effective treatment to patients from every economic background. “Innovation in the form of cellular therapy aims to regenerate, rejuvenate and restore the organs and tissues affected by disease. By utilizing our body’s own repair mechanisms, we can in the future treat diseases by not pills but cells”, says Dr. Mahajan.